Twist Bioscience (TWST) Profit After Tax (2017 - 2026)
Twist Bioscience has reported Profit After Tax over the past 10 years, most recently at -$44.0 million for Q1 2026.
- Quarterly Profit After Tax fell 11.93% to -$44.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$81.3 million through Mar 2026, up 57.48% year-over-year, with the annual reading at -$77.7 million for FY2025, 62.79% up from the prior year.
- Profit After Tax was -$44.0 million for Q1 2026 at Twist Bioscience, down from -$30.5 million in the prior quarter.
- Over five years, Profit After Tax peaked at $20.4 million in Q2 2025 and troughed at -$85.6 million in Q2 2024.
- The 5-year median for Profit After Tax is -$44.0 million (2026), against an average of -$43.4 million.
- Year-over-year, Profit After Tax plummeted 59.99% in 2022 and then soared 123.84% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$41.8 million in 2022, then fell by 2.83% to -$43.0 million in 2023, then rose by 26.54% to -$31.6 million in 2024, then grew by 3.46% to -$30.5 million in 2025, then tumbled by 44.33% to -$44.0 million in 2026.
- Per Business Quant, the three most recent readings for TWST's Profit After Tax are -$44.0 million (Q1 2026), -$30.5 million (Q4 2025), and -$27.1 million (Q3 2025).